A balancing act in Parkinson's disease: Phosphorylation of alpha-synuclein

Oct 12, 2009

Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Previous studies have indicated that phosphorylation of alpha-synuclein at amino acid 129 (Ser129) is a key event in alpha-synuclein-mediated nerve cell toxicity. However, Mel Feany and colleagues, at Brigham and Women's Hospital, Boston, have now identified a counterbalancing role in nerve cell protection for phosphorylation of alpha-synuclein amino acid 125 (Tyr125).

In the study, of human alpha-synuclein Tyr125 was detected in transgenic for human alpha-synuclein and shown to protect from alpha-synuclein-mediated nerve cell toxicity in a Drosophila model of Parkinson disease. That the two phosphorylated amino acids have opposing roles was indicated by the observation that Tyr125 phosphorylation decreased levels of toxic soluble alpha-synuclein oligomers in the Drosophila , whereas Ser129 phosphorylation increased them.

More importantly, Tyr125 phosphorylation was found to decrease as both humans and Drosophila aged and was reduced in cortical tissue from patients with synucleinopathy with Lewy bodies, a disease related to Parkinson disease. The authors therefore suggest that changes in the balance between Ser129 and Tyr125 phosphorylation — which promote nerve cell toxicity and protection, respectively — might cause alpha-synuclein-mediated nerve cell toxicity in Parkinson disease and related disorders.

More information: View this article at: www.jci.org/articles/view/3908… 59af0a7e79b38662c2ee

Source: Journal of Clinical Investigation

Explore further: Cooler bedroom temperatures may boost metabolic activity

add to favorites email to friend print save as pdf

Related Stories

Out-of-whack protein may boost Parkinson's

Feb 26, 2008

A single change in a protein may play a role in whether someone develops Parkinson’s disease, say University of Florida Genetics Institute researchers writing in a recent issue of the Proceedings of the National Academy of ...

Toxicity mechanism identified for Parkinson's disease

Jan 02, 2009

Neurologists have observed for decades that Lewy bodies, clumps of aggregated proteins inside cells, appear in the brains of patients with Parkinson's disease and other neurodegenerative diseases.

Study identifies novel Parkinson's disease drug target

Jun 21, 2007

Researchers at the MassGeneral Institute for Neurodegenerative Disease (MGH-MIND) have identified a potential new drug target for the treatment of Parkinson’s disease and possibly for other degenerative neurological disorders.

Lessons from yeast: A possible cure for Parkinson's disease?

Aug 14, 2008

Parkinson disease (PD) is a debilitating and lethal neurodegenerative disease, for which there is currently no cure. It is caused by the progressive loss of nerve cells that produce the chemical dopamine and is characterized ...

Recommended for you

User comments : 0